Any decision to stop or adjust these medications should happen under a doctors care
Although GLP-1 RAs have demonstrated efficacy and offer hope, obesity remains challenging and individual outcomes vary
Meaningful weight loss typically becomes apparent within the first 812 weeks of treatment, with continued progression throughout the first year
Conclusion China holds an important position in the global tirzepatide production and market competition due to its abundant and stable raw material supply, strong technological innovation capabilities, complete industrial chain support, professional talent reserve, and favorable policy support and industrial environment
The rate of weight loss on Semaglutide can vary depending on several individual factors including a patients starting weight, participation, and adherence to treatment, and lifestyle changes
Certification does two things at once